GSK and Pfizer Merging Consumer Health Businesses

GALWAY, IRELAND--January 14, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) and Pfizer (NYSE:PFE) (New York, New York) have announced plans to merge their consumer healthcare divisions with combined sales of approximately £9.8 billion ($12.7 billion).

Within this article: Details proposed merger, value, product lines affected, impact on manufacturing and jobs